AI-assisted molecular design of quinolone alkaloid analogues as pancreatic lipase inhibitor candidates

Open Access

Issue		BIO Web Conf. Volume 232, 2026 2026 16^th International Conference on Bioscience, Biochemistry and Bioinformatics (ICBBB 2026)


Article Number		02001
Number of page(s)		10
Section		Computer-Aided Drug Design and Molecular Simulation
DOI		https://doi.org/10.1051/bioconf/202623202001
Published online		24 April 2026

F. Ren, A. Aliper, J. Chen, H. Zhao, S. Rao, C. Kuppe, I. V. Ozerov, M. Zhang, K. Witte, C. Kruse, V. Aladinskiy, Y. Ivanenkov, D. Polykovskiy, Y. Fu, E. Babin, J. Qiao, X. Liang, Z. Mou, H. Wang, F.W. Pun, P. Torres-Ayuso, A. Veviorskiy, D. Song, S. Liu, B. Zhang, V. Naumov, X. Ding, A. Kukharenko, E. Izumchenko, A. Zhavoronkov, A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat. Biotechnol. 43, 63 (2025). https://doi.org/10.1038/s41587-024-02143-0 [Google Scholar]
GBD 2021 Risk Factors Collaborators, Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403, 2162 (2024). https://doi.org/10.1016/S0140-6736(24)00933-4 [Google Scholar]
GBD 2021 Adult BMI Collaborators, Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405, 813 (2025). https://doi.org/10.1016/S0140-6736(25)00355-1 [Google Scholar]
Z. Zheng, Y. Zong, Y. Ma, Y. Tian, Y. Pang, C. Zhang, J. Gao, Glucagon-like peptide-1 receptor: mechanisms and advances in therapy. Signal Transduct. Target. Ther. 9, 234 (2024). https://doi.org/10.1038/s41392-024-01931-z [Google Scholar]
M.-P. Egloff, F. Marguet, G. Buono, R. Verger, C. Cambillau, H. van Tilbeurgh, The 2.46 A resolution structure of the pancreatic lipase-colipase complex inhibited by a C11 alkyl phosphonate. Biochemistry 34, 275 (1995). https://doi.org/10.1021/bi00009a003 [Google Scholar]
A. M. Heck, J. A. Yanovski, K. A. Calis, Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20, 270 (2000). https://doi.org/10.1592/phco.20.4.270.34882 [Google Scholar]
Y. Zhai, K. Wang, Z. Yu, S. Zhou, J. Fan, Pancreatic lipase inhibitors: virtual screening and mechanistic analysis. Int. J. Biol. Macromol. 310, 143128 (2025). https://doi.org/10.1016/i.iibiomac.2025.143128 [Google Scholar]
A. Gholami, D. Minai-Tehrani, L.A. Eriksson, Combining kinetics and in silico approaches to evaluate bromhexine as an anti-pancreatic lipase agent for obesity management. Sci. Rep. 15, 18420 (2025). https://doi.org/10.1038/s41598-025-02625-4 [Google Scholar]
Y. Matsuo, T. Nozaki, Y. Kamewada, M. Nakagawa, Y. Nakamura, N. Inaba, Y. Mimaki, New quinolone alkaloids from Euodia fruit, and their pancreatic lipase inhibitory and PPAR-y ligand-binding activities. Fitoterapia 180, 106322 (2025). https://doi.org/10.1016/i.fitote.2024.106322 [Google Scholar]
S. Tripathi, R. H. Cote and H. Vashisth, Coupling of conformational dynamics and inhibitor binding in the phosphodiesterase-5 family, Protein Sci. 32, e4720 (2023). https://doi.org/10.1002/pro.4720 [Google Scholar]
A. Kobayashi, M. Nakaiima, Y. Noguchi, R. Morikawa, Y. Matsuo, and M. Takasu, Molecular Dynamics Simulation of the Complex of PDE5 and Evodiamine. Life 13(2), 578 (2023). https://doi.org/10.3390/life13020578 [Google Scholar]
S. Nanio, Arifin, H. Maeda, Y. Hayashi, K. Hatakeyama-Sato, R. Himeno, T. Hayakawa, R. Yoshida, SPACIER: on-demand polymer design with fully automated all-atom classical molecular dynamics integrated into machine learning pipelines. NPJ Comput. Mater. 11, 16 (2025). https://doi.org/10.1038/s41524-024-01492-3 [Google Scholar]
S. Rocha, C. Proença, A.N. Araújo, M. Freitas, I. Rufino, N. Aniceto, A.M.S. Silva, F. Carvalho, R.C. Guedes, E. Fernandes, Flavonoids as potential modulators of pancreatic lipase catalytic activity. Pharmaceutics 17, 163 (2025). https://doi.org/10.3390/pharmaceutics17020163 [Google Scholar]
P. T. V. Nguyen, H. A. Huynh, D. V. Truong, T.-D. Tran, C.-V. T. Vo, Exploring aurone derivatives as potential human pancreatic lipase inhibitors through molecular docking and molecular dynamics simulations. Molecules 25, 4657 (2020). https://doi.org/10.3390/molecules25204657 [Google Scholar]
C.-T. Vo, T. T. Nguyen, T. N. Danga, M. Q. Dao, V. T. Vo, O. T. Tran, L. T. V, T.-D. Tran, Design, synthesis, biological evaluation and molecular docking of alkoxyaurones as potent pancreatic lipase inhibitors, Bioorg. Med. Chem. Lett. 98 129574 (2024). https://doi.org/10.1016/i.bmcl.2023.129574 [Google Scholar]
J. Eberhardt, D. Santos-Martins, A. F. Tillack, S. Forli, AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings. J. Chem. Inf. Model. 61, 3891 (2021). https://doi.org/10.1021/acs.icim.1c00203 [Google Scholar]
E. F. Pettersen, T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, T. E. Ferrin, UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605 (2004). https://doi.org/10.1002/icc.20084 [Google Scholar]
N. M. O Boyle, M. Banck, C. A. James, C. Morley, T. Vandermeersch, G.R. Hutchison, Open Babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011). https://doi.org/10.1186/1758-2946-3-33 [Google Scholar]
S. Wu, G. Lambard, C. Liu, H. Yamada, R. Yoshida, iQSPR in XenonPy: a Bayesian molecular design algorithm. Mol. Inf. 39, 1900107 (2020). https://doi.org/10.1002/minf.201900107 [Google Scholar]
H. Ikebata, K. Hongo, T. Isomura, R. Maezono, R. Yoshida, Bayesian molecular design with a chemical language model. J. Comput. Aided Mol. Des. 31, 379–391 (2017). https://doi.org/10.1007/s10822-016-0008-z [Google Scholar]
A. Kumar, S. Chauhan, Pancreatic lipase inhibitors: the road voyaged and successes. Life Sci. 271, 119115 (2021). https://doi.org/10.1016/i.lfs.2021.119115 [Google Scholar]
S. Kim, J. Chen, T. Cheng, A. Gindulyte, J. He, S. He, Q. Li, B.A. Shoemaker, P.A. Thiessen, B. Yu, L. Zaslavsky, J. Zhang, E. E. Bolton, PubChem 2023 update. Nucleic Acids Res. 51, D1373(2023). https://doi.org/10.1093/nar/gkac956 [Google Scholar]
D. Rogers, M. Hahn, Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742–754 (2010). https://doi.org/10.1021/ci100050t [Google Scholar]
J. L. Durant, B. A. Leland, D. R. Henry, J. G. Nourse, Reoptimization of MDL keys for use in drug discovery. J. Chem. Inf. Comput. Sci. 42, 1273 (2002). https://doi.org/10.1021/ci010132r [Google Scholar]
L. McInnes, J. Healy, J. Melville, UMAP: Uniform manifold approximation and projection for dimension reduction. arXiv:1802.03426v3 (2018). https://doi.org/10.48550/arXiv.1802.03426 [Google Scholar]
P. Ertl, A. Schuffenhauer, Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. J. Cheminform. 1, 8 (2009). https://doi.org/10.1186/1758-2946-1-8 [Google Scholar]
G. R. Bickerton, G. V. Paolini, J. Besnard, S. Muresan, A.L. Hopkins, Quantifying the chemical beauty of drugs. Nat. Chem. 4, 90 (2012). https://doi.org/10.1038/nchem.1243 [Google Scholar]
A. K. Ghose, V. N. Viswanadhan, J. J. Wendoloski, Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods. J. Phys. Chem. A 102, 3762 (1998). https://doi.org/10.1021/ip980230o [Google Scholar]
Schrödinger, L., W. DeLano, PyMOL. (2020). http://www.pymol. org/pymol [Google Scholar]
R.A. Laskowski, M.B. Swindells, LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778 (2011). https://doi.org/10.1021/ci200227u [Google Scholar]
C.A. Hunter, J.K.M. Sanders, The Nature of JJ-JJInteractions, J. Am. Chem. Soc. 112, 5525 (1990). https://doi.org/10.1021/ia00170a016 [Google Scholar]
S. Nakamura, N. Yasuo, M. Sekijima, Molecular optimization using a conditional transformer for reaction-aware compound exploration with reinforcement learning, Commun. Chem. 8, 40 (2025). https://doi.org/10.1038/s42004-025-01437-x [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.